Alyeska Investment Group’s Veracyte VCYT Stock Holding History

Alyeska Investment Group’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26M	Buy	808,570 +207,014	+34%	+$7.66M	0.07%	285
2025 Q4	$25.3M	Buy	601,556 +293,503	+95%	+$11.8M	0.07%	277
2025 Q3	$10.6M	Buy	+308,053	New	+$8.84M	0.03%	368
2021 Q4	–	Sell	-203,129	Closed	-$9.44M	–	733
2021 Q3	$9.44M	Buy	203,129 +2,559	+1%	+$112K	0.12%	207
2021 Q2	$8.02M	Buy	200,570 +17,645	+10%	+$755K	0.09%	250
2021 Q1	$9.83M	Buy	+182,925	New	+$10.5M	0.13%	205
2019 Q4	–	Sell	-204,879	Closed	-$4.92M	–	498
2019 Q3	$4.92M	Sell	204,879 -6,303	-3%	-$168K	0.07%	229
2019 Q2	$6.02M	Buy	+211,182	New	+$5.28M	0.08%	213
2014 Q2	–	Sell	-185,919	Closed	-$3.19M	–	459
2014 Q1	$3.19M	Sell	185,919 -55,838	-23%	-$892K	0.09%	233
2013 Q4	$3.5M	Buy	+241,757	New	+$3.15M	0.14%	193

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Alyeska Investment Group's VCYT Position: Q1 2026 in Review

Alyeska Investment Group increased its Veracyte (VCYT) stake by 34% in Q1 2026, buying an estimated $7.66M and bringing the position to 808,570 shares worth $26M. The position accounts for 0.07% of the portfolio, ranked #285.

Alyeska Investment Group first reported a position in VCYT in Q4 2013 and has held it in 10 quarters since. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Alyeska Investment Group held 808,570 shares of Veracyte worth $26M as of Q1 2026.
Alyeska Investment Group bought 207,014 Veracyte shares in Q1 2026, an estimated $7.66M.
Veracyte made up 0.07% of Alyeska Investment Group's portfolio in Q1 2026, its #285 holding.
Alyeska Investment Group first reported a position in Veracyte in Q4 2013 and has held it in 10 quarters since.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.